microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma

Zhu,Xu-Chao; Dong,Qiong-Zhu; Zhang,Xiao-Fei; Deng,Biao; Jia,Hu-Liang; Ye,Qin-Hai; Qin,Lun-Xiu; Wu,Xing-Zhong

doi:10.3892/ijmm.2012.1140

microRNA-29a suppresses cell proliferation by targeting SPARC in hepatocellular carcinoma

Authors:
- Xu-Chao Zhu
- Qiong-Zhu Dong
- Xiao-Fei Zhang
- Biao Deng
- Hu-Liang Jia
- Qin-Hai Ye
- Lun-Xiu Qin
- Xing-Zhong Wu
View Affiliations

Affiliations: Department of Biochemistry and Molecular Biology, Shanghai Medical College, Fudan University, Key Laboratory of Glycoconjugate Research, Ministry of Public Health, Shanghai 200032, P.R. China, Liver Cancer Institute and Zhongshan Hospital, Institutes of Biomedical Sciences, Fudan University, Key Laboratory of Carcinogenesis and Cancer Invasion, Ministry of Education, Shanghai 200032, P.R. China
Published online on: September 25, 2012 https://doi.org/10.3892/ijmm.2012.1140
Pages: 1321-1326

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

In the present study, we constructed a lentivirus vector encoding the miR-29a precursor and established two stably infected cell lines, PLC-29a and 97L-29a. The overexpression of miR-29a was confirmed by TaqMan RT-PCR and significantly suppressed the growth of the hepatocellular carcinoma cell lines MHCC-97L and PLC. Dual-luciferase reporter assays indicated that the SPARC mRNA 3'UTR was directly targeted by miR-29a since the mutated 3'UTR was not affected. Silencing SPARC expression by RNAi knockdown resulted in a similar effect as miR-29a overexpression on hepatocellular carcinoma (HCC) cell growth regulation. Anti-miR-29a oligonucleotides (AMOs) upregulated the levels of SPARC in the HCC cells. The phosphorylation of AKT/mTOR downstream of SPARC was inhibited in miR-29a-overexpressing HCC cells. We further examined and compared the expression levels of miR-29a in HCC tissues and the corresponding nearby non-cancerous liver tissues of 110 patients with HCC by qRT-PCR, and significantly lower expression of miR-29a was observed in the tissues affected by HCC. Our findings demonstrate that the expression of miR-29a is important in the regulation of the SPARC-AKT pathway and HCC growth.

View Figures

View References

1.	KW BurakNM KnetemanAn evidence-based multidisciplinary approach to the management of hepatocellular carcinoma (HCC): the Alberta HCC algorithmCan J Gastroenterol24643650201021157578
2.	SF LiAM HawxbyR KanagalaH WrightA SebastianLiver transplantation for hepatocellular carcinoma: indications, bridge therapy and adjuvant therapyJ Okla State Med Assoc1051216201222458042
3.	C BouzinO FeronTargeting tumor stroma and exploiting mature tumor vasculature to improve anti-cancer drug deliveryDrug Resist Updat10109120200710.1016/j.drup.2007.03.00117452119
4.	SR AlonsoL TraceyP OrtizA high-throughput study in melanoma identifies epithelial-mesenchymal transition as a major determinant of metastasisCancer Res6734503460200710.1158/0008-5472.CAN-06-348117409456
5.	Q ShiS BaoJA MaxwellSecreted protein acidic, rich in cysteine (SPARC), mediates cellular survival of gliomas through AKT activationJ Biol Chem2795220052209200410.1074/jbc.M40963020015469933
6.	R ThomasLD TrueJA BassukPH LangeRL VessellaDifferential expression of osteonectin/SPARC during human prostate cancer progressionClin Cancer Res611401149200010741745
7.	SK ChanOL GriffithIT TaiSJ JonesMeta-analysis of colorectal cancer gene expression profiling studies identifies consistently reported candidate biomarkersCancer Epidemiol Biomarkers Prev17543552200810.1158/1055-9965.EPI-07-261518349271
8.	CP LauRT PoonST CheungWC YuST FanSPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinomaJ Pathol210459468200610.1002/path.206817029219
9.	CY JiaHH LiXC ZhuMiR-223 suppresses cell proliferation by targeting IGF-1RPLoS One6e27008201110.1371/journal.pone.002700822073238
10.	LH WuHH LiCY JiaMicroRNA-223 regulates FOXO1 expression and cell proliferationFEBS Lett58610381043201210.1016/j.febslet.2012.02.05022569260
11.	F MengR HensonH Wehbe-JanekK GhoshalST JacobT PatelMicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancerGastroenterology133647658200710.1053/j.gastro.2007.05.02217681183
12.	A BudhuHL JiaM ForguesIdentification of metastasis-related microRNAs in hepatocellular carcinomaHepatology47897907200810.1002/hep.2216018176954
13.	J HouL LinW ZhouIdentification of miRNomes in human liver and hepatocellular carcinoma reveals miR-199a/b-3p as therapeutic target for hepatocellular carcinomaCancer Cell19232243201110.1016/j.ccr.2011.01.00121316602
14.	Y XiongJH FangJP YunEffects of microRNA-29 on apoptosis, tumorigenicity, and prognosis of hepatocellular carcinomaHepatology51836845201020041405
15.	R LiN QianK TaoN YouX WangK DouMicroRNAs involved in neoplastic transformation of liver cancer stem cellsJ Exp Clin Cancer Res29169201010.1186/1756-9966-29-16921176238
16.	B WangR KomersR CarewSuppression of microRNA-29 expression by TGF-beta1 promotes collagen expression and renal fibrosisJ Am Soc Nephrol23252265201210.1681/ASN.201101005522095944
17.	P ZhangA HuangJ FerruzziInhibition of microRNA-29 enhances elastin levels in cells haploinsufficient for elastin and in bioengineered vessels - brief reportArterioscler Thromb Vasc Biol32756759201210.1161/ATVBAHA.111.23811322095981
18.	AS PapadopoulouJ DooleyMA LintermanThe thymic epithelial microRNA network elevates the threshold for infection-associated thymic involution via miR-29a mediated suppression of the IFN-alpha receptorNat Immunol13181187201210.1038/ni.2193
19.	S TeichlerT IllmerJ RoemhildD OvcharenkoT StieweA NeubauerMicroRNA29a regulates the expression of the nuclear oncogene SkiBlood11818991902201110.1182/blood-2010-09-30625821685371
20.	AK PandeyG VermaS VigS SrivastavaAK SrivastavaM DattamiR-29a levels are elevated in the db/db mice liver and its overexpression leads to attenuation of insulin action on PEPCK gene expression in HepG2 cellsMol Cell Endocrinol332125133201110.1016/j.mce.2010.10.00420943204
21.	C DesjobertMH RenalierJ BergaletMiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpressionBlood11766276637201110.1182/blood-2010-09-30199421471522
22.	JL MottS KuritaSC CazanaveSF BronkNW WerneburgME Fernandez-ZapicoTranscriptional suppression of mir-29b-1/mir-29a promoter by c-Myc, hedgehog, and NF-kappaBJ Cell Biochem11011551164201010.1002/jcb.2263020564213
23.	S HuangX HeThe role of microRNAs in liver cancer progressionBr J Cancer104235240201110.1038/sj.bjc.660601021102580
24.	C RoderburgGW UrbanK BettermannMicro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosisHepatology53209218201110.1002/hep.2392220890893
25.	G KongJ ZhangS ZhangC ShanL YeX ZhangUpregulated microRNA-29a by hepatitis B virus X protein enhances hepatoma cell migration by targeting PTEN in cell culture modelPLoS One6e19518201110.1371/journal.pone.001951821573166